Class I Innovative Drug — Deuterated Enzalutamide Soft...

agregó una foto Health

2025-10-27 08:38:14 -

Class I Innovative Drug — Deuterated Enzalutamide Soft Capsules Approved for Market Launch!A Breakthrough in China’s Prostate Cancer Treatment with a Homegrown Innovation!

According to information obtained from the official website of Hong Kong DengYue Medicine, the Class I innovative drug Haina’an® (generic name: Deuterated Enzalutamide Soft Capsules) has been approved for marketing in China.This therapy is indicated for adult patients with metastatic castration-resistant prostate cancer (mCRPC) who have progressed after treatment with...

0 Commentarios 0 Acciones 202 Views 0 Vista previa